BNP Paribas Financial Markets’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,894
Closed -$1.62M 4262
2020
Q3
$1.62M Buy
11,894
+8,878
+294% +$944K ﹤0.01% 1600
2020
Q2
$291K Sell
3,016
-11,935
-80% -$996K ﹤0.01% 2332
2020
Q1
$701K Buy
14,951
+8,567
+134% +$549K ﹤0.01% 2156
2019
Q4
$465K Sell
6,384
-1,599
-20% -$97K ﹤0.01% 2504
2019
Q3
$416K Buy
7,983
+3,212
+67% +$171K ﹤0.01% 2313
2019
Q2
$239K Sell
4,771
-3,142
-40% -$153K ﹤0.01% 2500
2019
Q1
$411K Buy
7,913
+7,256
+1,104% +$334K ﹤0.01% 2226
2018
Q4
$32.1K Sell
657
-1,060
-62% -$58.4K ﹤0.01% 2929
2018
Q3
$112K Buy
1,717
+440
+34% +$25.9K ﹤0.01% 2678
2018
Q2
$63.4K Sell
1,277
-2,815
-69% -$136K ﹤0.01% 3013
2018
Q1
$200K Sell
4,092
-45
-1% -$2.34K ﹤0.01% 2795
2017
Q4
$174K Buy
4,137
+2,366
+134% +$91.2K ﹤0.01% 3030
2017
Q3
$75.9K Sell
1,771
-98
-5% -$3.13K ﹤0.01% 2925
2017
Q2
$24.5K Buy
1,869
+1,789
+2,236% +$23.6K ﹤0.01% 3546
2017
Q1
$1.05K Sell
80
-136
-63% -$1.74K ﹤0.01% 3686
2016
Q4
$2.8K Sell
216
-580
-73% -$8.93K ﹤0.01% 3861
2016
Q3
$13K Buy
796
+395
+99% +$7.13K ﹤0.01% 3100
2016
Q2
$4.97K Buy
+401
New +$5.01K ﹤0.01% 3274
2016
Q1
Sell
-1,118
Closed -$16.4K 3270
2015
Q4
$16.4K Buy
+1,118
New +$13.7K ﹤0.01% 3329

BNP Paribas Financial Markets's MYOK Position: Q4 2020 in Review

BNP Paribas Financial Markets sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 11,894 shares — an estimated $1.62M sold.

BNP Paribas Financial Markets first reported a position in MYOK in Q4 2015 and held it in 19 quarters. The position peaked at $1.62M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • BNP Paribas Financial Markets reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 11,894 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.62M.
  • BNP Paribas Financial Markets first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 19 quarters.
  • BNP Paribas Financial Markets's MyoKardia, Inc. Common Stock position peaked at $1.62M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.